24/7 Wall Street
12 Sept 2026, 14:50 UTC · 8w ago
The Closest Thing to Set-It-and-Forget-It Income: 5 Dividend Kings for Retirees Who Want Peace of Mind
Impact · against what's priced in
The article provides mostly confirmatory data for JNJ and EMR, as their recent guidance and cash flow surges are already reflected in current valuations. However, the identified $1 billion cost headwind for PG and the planned 2027 split for GPC introduce specific operational and policy risks that may not be fully absorbed.
- EMR+0.00
Already priced in
- The price assumes
The continuation of current, modest growth: the price assumes the 3.0% overall revenue growth and 14.8% free cash flow margin





